ELVN Earnings Date: Nov 11, 2026 (Estimated) — Enliven Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ELVN's next earnings date?
Enliven Therapeutics, Inc. (ELVN) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.45.
How did ELVN do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Enliven Therapeutics, Inc. posted EPS of -$0.49 versus the -$0.39 estimate, a miss of 32.4%. Revenue was $0. The stock's 1-day post-earnings move was +1.0%.
How much does ELVN stock move after earnings?
ELVN beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 1.8% (up or down) in the day after earnings.
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule kinase inhibitor, has begun a Phase 1 clinical assessment for individuals with cancers exhibiting an abnormal HER2 gene. The company's base of operations is located in Boulder, Colorado.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | -0.39 | -0.49 | -32.43% | $0 | ❌ Miss | +0.95% | -2.98% | -0.08% |
| 2026-05-07 | Q1 2026 | -0.42 | -0.38 | +9.52% | $0 | ✅ Beat | +1.14% | +6.92% | -16.53% |
| 2026-03-03 | Q4 2025 | -0.45 | -0.48 | -6.67% | $0 | ❌ Miss | +4.28% | +5.18% | +31.44% |
| 2025-11-12 | Q3 2025 | -0.45 | -0.32 | +28.89% | $0 | ✅ Beat | -0.15% | +8.87% | -16.95% |
| 2025-08-13 | Q2 2025 | -0.46 | -0.49 | -6.52% | $0 | ❌ Miss | -1.08% | -1.63% | -0.13% |
| 2025-03-13 | Q4 2024 | -0.52 | -0.46 | +11.54% | $0 | ✅ Beat | +2.22% | +3.10% | -18.63% |
| 2024-11-13 | Q3 2024 | -0.50 | -0.48 | +4.00% | $0 | ✅ Beat | -3.41% | -1.43% | -10.27% |
| 2024-08-13 | Q2 2024 | -0.55 | -0.41 | +25.45% | $0 | ✅ Beat | +1.30% | +3.62% | +3.76% |
Showing last 8 quarters.